|
|
Volumn 145, Issue 4, 2001, Pages 667-668
|
|
Current causes of fixed drug eruption ill the U.K. [1]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMLODIPINE;
AMOXICILLIN;
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
BARBITURIC ACID DERIVATIVE;
CALCIUM CHANNEL BLOCKING AGENT;
CARBAMAZEPINE;
DILTIAZEM;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
FLUCONAZOLE;
FLUOXETINE;
HORMONE;
IBUPROFEN;
LAMOTRIGINE;
LANSOPRAZOLE;
MEFENAMIC ACID;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
OMEPRAZOLE;
PARACETAMOL;
PHENOLPHTHALEIN;
PROTON PUMP INHIBITOR;
PSYCHOTROPIC AGENT;
SALAZOSULFAPYRIDINE;
TERBINAFINE;
TETRACYCLINE DERIVATIVE;
TRIMETHOPRIM;
UNINDEXED DRUG;
DERMATOLOGY;
DRUG ERUPTION;
DRUG USE;
HUMAN;
LETTER;
PRESCRIPTION;
PRIORITY JOURNAL;
QUESTIONNAIRE;
SIDE EFFECT;
UNITED KINGDOM;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
DRUG ERUPTIONS;
GREAT BRITAIN;
HUMANS;
|
|
EID: 0035788784
PISSN: 00070963
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2133.2001.04422.x Document Type: Letter |
|
Times cited : (42)
|
|
References (2)
|
